The Industrial Asset Management Council's Health & Science Companies Industry Group, led by Sean Nugent of Pfizer and Mert Livingstone of Johnson & Johnson, has developed a descriptive and prescriptive white paper on pharmaceuticals industry surplus facilities. The white paper identifies and explores some of the many issues currently faced by pharmaceutical and biotech companies with surpluses of industrial assets.
Souderton, Pa.-based Almac Clinical Technologies has been recognized as a top place to work in Pennsylvania by a partnership of public and private organizations. The company was cited for its heavy investment in employee development.
Eli Lilly will focus on diabetes in China at a new research center planned for Shanghai. The center is scheduled to open during the second half of 2011.
Bloomberg reports that Israeli life science firms are finding Ohio locations especially attractive. State incentives and the availability of venture capital are among the reasons cited.
Medicago USA, a subsidiary of Quebec City-based vaccine maker Medicago, has been awarded nearly $250,000 under the Internal Revenue Service's Qualifying Therapeutic Discovery Project The company announced plans earlier this year for a manufacturing facility in North Carolina.
Positive public opinion of the life sciences sector is on the rise in Europe. That is the finding of a survey by the European Commission. However, there is a significant thirst for knowledge about biotechnology.
A new study supported by the Medical Device Manufacturers Association and the National Venture Capital Association finds that inefficiencies at the Food and Drug Administration delay patient access and increase costs of new medical technologies.